First published on 3 August 2017, this article in the Washington Post discusses recently passed ‘Right to Try’ legislation, aiding access to treatments for terminally ill patients.

The Senate on Thursday passed by unanimous consent a measure designed to make it easier for terminally ill patients to get access to experimental treatments without oversight from the Food and Drug Administration.

Click here to see the full article.